News

Researchers have made a breakthrough discovery that could potentially revolutionize treatments for antibiotic-resistant infections, cancer and other challenging gram-negative pathogens without relying ...
Researchers at the University of Oklahoma have made a discovery that could potentially revolutionize treatments for ...
UTIs are the cause of roughly 8 million emergency room visits and 100,000 hospitalizations in the US each year, GSK said.
As spotted by GameSpot, the contraband food dye is “Blue No. 1" and can be found in the Minecraft Movie milk’s list of ...
Now, after nearly three decades, the U.S. Food and Drug Administration (FDA) has approved Blujepa (gepotidacin), a new oral antibiotic from GSK, offering fresh hope for those struggling with ...
Dr. Brian Barnett shows the inside of the dosing room at Cleveland Clinic Lutheran where participants in a study looking at ...
Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials ...
Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and ...
A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a ...
University of Oklahoma researchers use blue light and iron to create bioactive sugars to develop novel antibiotics against multi-drug-resistant infections in cancer patients NORMAN, OKLA.